Heparin Binding Protein in Early Sepsis Diagnosis (PROMPT)
Prospective Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein Assay to Indicate the Presence and Outcome of Sepsis in Patients With Suspected Infection Following Emergency Department Admission
Sponsor: Aristotle University Of Thessaloniki
A NA clinical study on Infection and Sepsis, this trial is completed. The trial is conducted by Aristotle University Of Thessaloniki and has accumulated 8 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Nov 2018 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
-
Oct 2017 — Nov 2017 [monthly]
Recruiting NA
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aristotle University Of Thessaloniki
- Hellenic Institute for the Study of Sepsis
- National and Kapodistrian University of Athens
For direct contact, visit the study record on ClinicalTrials.gov .